Biologic drugs in pediatric rheumatology

Biologic agents in rheumatology: act II.

Division of Rheumatology, Allergy and Immunology, Center for Innovative Therapy (CIT), University of California, La Jolla, USA. Please address correspondence to: Arthur Kavanaugh, MD, Professor of Medicine, Division of Rheumatology, Allergy and Immunology, Center for Innovative Therapy (CIT), University of California, La Jolla, CA 92093-7044, USA. E-mail: [email protected] Received and accept...

Pediatric rheumatology

Objective Examining for gastrointestinal involvement in juvenile idiopathic arthritis is an important part of diagnostic and therapeutic procedures. Only few scientific data are available.

[The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet].

L e principali artriti croniche ad eziopatogene-si immunoflogistica, nelle quali trovano ap-plicazione i farmaci " biologici " (v. oltre) sono la reumatoide e le sieronegative: artrite psoriasica, spondilite anchilosante, artriti reattive ed artriti " enteropatiche " (1-7). L'artrite reumatoide (AR) è una malattia cronica progressiva delle articolazioni associata a signifi-cativa morbilità, def...

Advances in pediatric rheumatology

[Update in pediatric rheumatology].

In recent decades many advances in paediatric rheumatology have been achieved, in particular in classification, outcome measurements, and therapeutic regimens. In particular, the collaborative effort of multicenter studies has helped to improve the recognition and treatment of less common rheumatic diseases in childhood. Due to a close cooperation among researchers in Europe and United States, ...